Zepp Health CORP 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NYSE
Zepp Health Corporation has filed an Amended and Restated 2015 Share Incentive Plan, outlining terms for granting options, restricted shares, and restricted share units to employees, consultants, and board members.
NYSE
Zepp Health Corporation files an amendment to its 2024 Annual Report on Form 20-F to include the financial statements of Jiangsu Yitong High-tech Co., Ltd., a significant equity method investee.
NYSE
Zepp Health Corporation's 20-F filing provides a comprehensive overview of the company's financial performance, operational structure, and associated risks for the fiscal year ended December 31, 2024.
NYSE
Zepp Health Corporation files an amendment to its 2023 annual report to include the financial statements of Jiangsu Yitong High-tech Co., Ltd., a significant equity method investee.
NYSE
Zepp Health Corporation's 20-F filing reveals a technology transfer agreement and provides insights into its corporate structure and financial performance.